BioTech Annecto Montreal is pleased to announce a presentation given by Dung Pham, PhD, Senior Medical Science Liaison at Alexion Pharmaceuticals, entitled:
RARE DOESN’T MEAN ORPHANED: The Future of Pharmaceutical?
Dung brings over 15 years of experience in pharmaceutical and clinical contract research organization (CRO) industries. He joined Alexion Pharmaceuticals as Senior MSL in 2016. Alexion is a global biopharmaceutical company focused on developing therapies for patients with devastating severe and ultra-rare diseases such as Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome.
Prior to Alexion, Dung worked as a Medical Advisor and Regional Medical Liaison at the major multinational companies, i.e Pfizer, Amgen, Bayer and Genzyme. He has extensive experience in pulmonary hypertension, ophthalmology, inflammation and rare diseases.
Dung holds a MSc and a PhD in Pharmacology from Université de Sherbrooke.
Who is invited?
Professionals in the following industries: pharmaceuticals, CROs, biotechnology, and medical technology, Health care and biomedical research
People seeking opportunities to enlarge their professional network in life science industries.
When and Where?
6:30pm to 9pm on Tuesday September 26, 2017
Pub L’île Noire
1649 rue St-Denis
Cost: $15 (up to 48h before the event) / $20 regular price / FREE if you purchase a yearly membership
Please login to the site, using LinkedIn preferably, to be able to register for the event.